Trial Profile
A Phase IV Trial of Cesamet Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Nabilone (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 24 Jan 2008 Status changed from recruiting to discontinued. This study was terminated because enrollment was too slow, accorind to ClinicalTrials.gov.
- 21 Aug 2006 New trial record.